A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He didn’t set a quit date. He simply lost interest. It happened without effort.
The PDUFA also allows drug companies to pay additional, voluntary fees to the agency to help pay for additional staffers—a move that has seen some positive benefits in an expedited review process. Although the FDA has an agreement in place with titans of the industry outlining metrics and timelines of such a process, those companies—and the FDA itself—have never directly paid staffers for meeting or exceeding timelines, until now.。关于这个话题，PDF资料提供了深入分析
，这一点在电影中也有详细论述
Go to worldnews
API and the test suite. The motivation: enabling relicensing from LGPL to MIT.，更多细节参见电影